Bioassay Services Agreement for Genetic SequencingBioassay Services Agreement • September 24th, 2024 • Kairos Pharma, LTD. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 24th, 2024 Company Industry JurisdictionThis Bioassay Services Agreement (“Agreement”) is made and entered into effective as of September 20, 2024 (the “Effective Date”) by and between PreCheck Health Services, Inc., a Florida-based corporation (“Service Provider”), and Kairos Pharma, Ltd., a Delaware-based corporation (“Client”). The Service Provider and Client are sometimes referred to in this Agreement individually as a “Party” and collectively as the “Parties.”